Search
for
Sort by
Research 481–510 of 1000+
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- A Systematic Review of Outcomes and Patient Satisfaction Following Surgical and Non-surgical Treatments for Hair Loss
- Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Untargeted Metabolomics and Steroid Signatures in Urine of Male Pattern Baldness Patients after Finasteride Treatment for a Year
- Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration
- Serum zinc and copper levels in alopecia
- Testosterone: The Male Sex Hormone
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Finasteride in Androgenic Alopecia
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Interactions between Damaged Hair Keratin and Juglone as a Possible Restoring Agent: A Vibrational and Scanning Electron Microscopy Study
- Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness
- Finasteride
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Alopecia and the Microbiome: A Future Therapeutic Target?
- An appraisal of laboratory models of androgenetic alopecia: A systematic review
- Cosmeceutical Potentials of Equisetum debile Roxb. ex Vaucher Extracts